Literature DB >> 24043312

Functional redundancy of Sos1 and Sos2 for lymphopoiesis and organismal homeostasis and survival.

Fernando C Baltanás1, Martín Pérez-Andrés, Alicia Ginel-Picardo, David Diaz, David Jimeno, Pilar Liceras-Boillos, Robert L Kortum, Lawrence E Samelson, Alberto Orfao, Eugenio Santos.   

Abstract

Sos1 and Sos2 are ubiquitously expressed, universal Ras guanine nucleotide exchange factors (Ras-GEFs) acting in multiple signal transduction pathways activated by upstream cellular kinases. The embryonic lethality of Sos1 null mutants has hampered ascertaining the specific in vivo contributions of Sos1 and Sos2 to processes controlling adult organism survival or development of hematopoietic and nonhematopoietic organs, tissues, and cell lineages. Here, we generated a tamoxifen-inducible Sos1-null mouse strain allowing analysis of the combined disruption of Sos1 and Sos2 (Sos1/2) during adulthood. Sos1/2 double-knockout (DKO) animals died precipitously, whereas individual Sos1 and Sos2 knockout (KO) mice were perfectly viable. A reduced percentage of total bone marrow precursors occurred in single-KO animals, but a dramatic depletion of B-cell progenitors was specifically detected in Sos1/2 DKO mice. We also confirmed a dominant role of Sos1 over Sos2 in early thymocyte maturation, with almost complete thymus disappearance and dramatically higher reduction of absolute thymocyte counts in Sos1/2 DKO animals. Absolute counts of mature B and T cells in spleen and peripheral blood were unchanged in single-KO mutants, while significantly reduced in Sos1/2 DKO mice. Our data demonstrate functional redundancy between Sos1 and Sos2 for homeostasis and survival of the full organism and for development and maturation of T and B lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24043312      PMCID: PMC3838185          DOI: 10.1128/MCB.01026-13

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  35 in total

1.  Ras-guanine nucleotide exchange factor sos2 is dispensable for mouse growth and development.

Authors:  L M Esteban; A Fernández-Medarde; E López; K Yienger; C Guerrero; J M Ward; L Tessarollo; E Santos
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

2.  K-Ras is essential for normal fetal liver erythropoiesis.

Authors:  Waleed F Khalaf; Hilary White; Mary Jo Wenning; Attilio Orazi; Reuben Kapur; David A Ingram
Journal:  Blood       Date:  2005-01-11       Impact factor: 22.113

Review 3.  Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy.

Authors:  L S Steelman; R A Franklin; S L Abrams; W Chappell; C R Kempf; J Bäsecke; F Stivala; M Donia; P Fagone; F Nicoletti; M Libra; P Ruvolo; V Ruvolo; C Evangelisti; A M Martelli; J A McCubrey
Journal:  Leukemia       Date:  2011-04-15       Impact factor: 11.528

Review 4.  Regulation of small GTPases by GEFs, GAPs, and GDIs.

Authors:  Jacqueline Cherfils; Mahel Zeghouf
Journal:  Physiol Rev       Date:  2013-01       Impact factor: 37.312

5.  Nucleolar disruption and cajal body disassembly are nuclear hallmarks of DNA damage-induced neurodegeneration in purkinje cells.

Authors:  Fernando C Baltanás; Iñigo Casafont; Eduardo Weruaga; José R Alonso; María T Berciano; Miguel Lafarga
Journal:  Brain Pathol       Date:  2010-11-30       Impact factor: 6.508

6.  M-CSF stimulated differentiation requires persistent MEK activity and MAPK phosphorylation independent of Grb2-Sos association and phosphatidylinositol 3-kinase activity.

Authors:  Stéphanie Gobert Gosse; Caroline Bourgin; Wang Qing Liu; Christiane Garbay; Guy Mouchiroud
Journal:  Cell Signal       Date:  2005-03-23       Impact factor: 4.315

7.  RasGRP is essential for mouse thymocyte differentiation and TCR signaling.

Authors:  N A Dower; S L Stang; D A Bottorff; J O Ebinu; P Dickie; H L Ostergaard; J C Stone
Journal:  Nat Immunol       Date:  2000-10       Impact factor: 25.606

8.  Unusual interplay of two types of Ras activators, RasGRP and SOS, establishes sensitive and robust Ras activation in lymphocytes.

Authors:  Jeroen P Roose; Marianne Mollenauer; Mary Ho; Tomohiro Kurosaki; Arthur Weiss
Journal:  Mol Cell Biol       Date:  2007-02-05       Impact factor: 4.272

9.  Inhibition of Grb2 expression demonstrates an important role in BCR-ABL-mediated MAPK activation and transformation of primary human hematopoietic cells.

Authors:  H Modi; L Li; S Chu; J Rossi; J-K Yee; R Bhatia
Journal:  Leukemia       Date:  2010-11-12       Impact factor: 11.528

10.  Serum-dependent transcriptional networks identify distinct functional roles for H-Ras and N-Ras during initial stages of the cell cycle.

Authors:  Esther Castellano; Carmen Guerrero; Alejandro Núñez; Javier De Las Rivas; Eugenio Santos
Journal:  Genome Biol       Date:  2009-11-06       Impact factor: 13.583

View more
  18 in total

1.  Ras GEF Mouse Models for the Analysis of Ras Biology and Signaling.

Authors:  Alberto Fernández-Medarde; Eugenio Santos
Journal:  Methods Mol Biol       Date:  2021

2.  Regulation of the Small GTPase Ras and Its Relevance to Human Disease.

Authors:  Kayla R Kulhanek; Jeroen P Roose; Ignacio Rubio
Journal:  Methods Mol Biol       Date:  2021

3.  Differential Role of the RasGEFs Sos1 and Sos2 in Mouse Skin Homeostasis and Carcinogenesis.

Authors:  Pilar Liceras-Boillos; David Jimeno; Rósula García-Navas; L Francisco Lorenzo-Martín; Mauricio Menacho-Marquez; Carmen Segrelles; Carmela Gómez; Nuria Calzada; Rocío Fuentes-Mateos; Jesús M Paramio; Xosé R Bustelo; Fernando C Baltanás; Eugenio Santos
Journal:  Mol Cell Biol       Date:  2018-07-30       Impact factor: 4.272

4.  Sos1 disruption impairs cellular proliferation and viability through an increase in mitochondrial oxidative stress in primary MEFs.

Authors:  P Liceras-Boillos; R García-Navas; A Ginel-Picardo; B Anta; M Pérez-Andrés; C Lillo; C Gómez; D Jimeno; A Fernández-Medarde; F C Baltanás; E Santos
Journal:  Oncogene       Date:  2016-05-09       Impact factor: 9.867

Review 5.  RAS, wanted dead or alive: Advances in targeting RAS mutant cancers.

Authors:  Clint A Stalnecker; Channing J Der
Journal:  Sci Signal       Date:  2020-03-24       Impact factor: 8.192

6.  BI-3406, a Potent and Selective SOS1-KRAS Interaction Inhibitor, Is Effective in KRAS-Driven Cancers through Combined MEK Inhibition.

Authors:  Marco H Hofmann; Michael Gmachl; Juergen Ramharter; Fabio Savarese; Daniel Gerlach; Joseph R Marszalek; Michael P Sanderson; Dirk Kessler; Francesca Trapani; Heribert Arnhof; Klaus Rumpel; Dana-Adriana Botesteanu; Peter Ettmayer; Thomas Gerstberger; Christiane Kofink; Tobias Wunberg; Andreas Zoephel; Szu-Chin Fu; Jessica L Teh; Jark Böttcher; Nikolai Pototschnig; Franziska Schachinger; Katharina Schipany; Simone Lieb; Christopher P Vellano; Jonathan C O'Connell; Rachel L Mendes; Jurgen Moll; Mark Petronczki; Timothy P Heffernan; Mark Pearson; Darryl B McConnell; Norbert Kraut
Journal:  Cancer Discov       Date:  2020-08-19       Impact factor: 39.397

7.  Unique dependence on Sos1 in Kras G12D -induced leukemogenesis.

Authors:  Xiaona You; Guangyao Kong; Erik A Ranheim; David Yang; Yun Zhou; Jing Zhang
Journal:  Blood       Date:  2018-10-30       Impact factor: 22.113

8.  Oncogenic RAS isoforms show a hierarchical requirement for the guanine nucleotide exchange factor SOS2 to mediate cell transformation.

Authors:  Erin Sheffels; Nancy E Sealover; Chenyue Wang; Do Hyung Kim; Isabella A Vazirani; Elizabeth Lee; Elizabeth M Terrell; Deborah K Morrison; Ji Luo; Robert L Kortum
Journal:  Sci Signal       Date:  2018-09-04       Impact factor: 8.192

9.  One-way membrane trafficking of SOS in receptor-triggered Ras activation.

Authors:  Sune M Christensen; Hsiung-Lin Tu; Jesse E Jun; Steven Alvarez; Meredith G Triplet; Jeffrey S Iwig; Kamlesh K Yadav; Dafna Bar-Sagi; Jeroen P Roose; Jay T Groves
Journal:  Nat Struct Mol Biol       Date:  2016-08-08       Impact factor: 15.369

10.  Critical requirement of SOS1 RAS-GEF function for mitochondrial dynamics, metabolism, and redox homeostasis.

Authors:  Rósula García-Navas; Pilar Liceras-Boillos; Carmela Gómez; Fernando C Baltanás; Nuria Calzada; Cristina Nuevo-Tapioles; José M Cuezva; Eugenio Santos
Journal:  Oncogene       Date:  2021-06-12       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.